 lysi autolog melanoma cell tumor-infiltr lymphocyt associ clinic respons tumor-infiltr lymphocyt til vitro medium clinic trial surgeri branch nation cancer institut patient metastat malign melanoma adopt transfer autolog til time treatment til vitro lysi fresh autolog allogen melanoma cell daudi cell patient clinic respons week lysi autolog tumor cell til patient tumor cell nonrespond patient sensit allogen lymphokine-activ killer lak cell differ til nonrespond patient lysi lak-sensit daudi cell low case til lysi autolog tumor cell due lak cell observ associ autolog tumor cell lysi til clinic respons develop cultur method lysi autolog tumor respons rate til treatment regimen